Article · 20 May 2025
Research articlePublished 26 Jul 2016
Purine and nonpurine pharmacological CDK inhibitors target initiation of viral transcription
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Antiviral drugs that target viral proteins are very successful but have certain limitations. Consequently, cellular proteins have begun to be considered as potential targets for novel antivirals. Cyclin-dependent kinases (CDKs) are arguably the cellular proteins best studied as potential targets. Several pharmacological CDK inhibitors (PCIs) have antiviral activity against wild-type or drug-resistant strains of HIV, human cytomegalovirus, herpes simplex virus (HSV), Epstein–Barr virus, varicella-zoster virus, Kaposi’s sarcoma herpesvirus, and human T-cell leukemia virus. Some PCIs such as roscovitine are apparently well tolerated and are scheduled to enter clinical trials as antivirals in 2005. However, the antiviral mechanisms of PCIs remain incompletely characterized, and PCIs with different molecular specificities may inhibit different viral functions. Objective: To evaluate whether PCIs with different molecular specificities target common viral functions. Methods: We evaluated the activities of structurally unrelated PCIs against a single model virus, HSV, in primary and immortalized fibroblasts. We tested whether roscovitine, flavopiridol, aloisine, and DRB, which preferentially inhibit different subsets of CDKs, inhibit HSV replication, transcription, or gene expression. Results: Aloisine was effective only in primary fibroblasts. Roscovitine, DRB, and to a lesser extent flavopiridol, inhibited HSV replication at lower concentrations in primary than in immortalized fibroblasts. These PCIs inhibited initiation of HSV transcription and accumulation of a viral protein into replication compartments. Flavopiridol also inhibited HSV transcription elongation. Conclusions: Structurally unrelated PCIs have common antiviral targets, although targets unique to certain PCIs also exist. We have identified two novel functional targets for antivirals, initiation of viral transcription and subcellular localization of viral proteins.
Keywords
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Practice.
Article · 20 May 2025
Histological effects of doxorubicin and baobab plants on some organs of rat
Article · 28 Mar 2025
Using
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Practice
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Jonathan J Lacasse”
- BylineArticles whose byline prints “Veronic MI Provencher”
- BylineArticles whose byline prints “Matthew D Urbanowski”
- BylineArticles whose byline prints “Luis M Schang”